Claudia Ventola

Claudia Ventola serves as a key procurement professional within the National Institutes of Health, supporting the agency’s mission to advance biomedical research through strategic acquisition of high-precision scientific infrastructure. She manages complex contracts for advanced laboratory instrumentation, specialized software, and technical services critical to hypothesis-driven life sciences research. Her work ensures researchers have access to cutting-edge analytical tools, biotechnology reagents, and computational platforms that enable data-intensive discovery and clinical translation. Ventola’s portfolio spans the full acquisition lifecycle—from market research and requirements definition to contract award and performance monitoring—aligning procurements with NIH’s scientific priorities and federal acquisition regulations. She maintains sustained partnerships with leading contractors including Leidos Biomedical Research Inc., Kelly Services, Inc., Fors Marsh Group LLC, PPD Development LP, and The Whiting-Turner Contracting Company, reflecting a blend of scientific services, staffing solutions, and facility support. Her relationships emphasize long-term collaboration with vendors capable of delivering specialized technical expertise, regulatory-compliant laboratory operations, and mission-critical IT infrastructure. These partnerships are typically structured as indefinite-delivery/indefinite-quantity (IDIQ) contracts or task orders requiring deep domain knowledge in life sciences and research support environments. Ventola’s contracting patterns show a strong preference for open competition, with 85.7% of awards issued without set-aside restrictions, while maintaining a consistent 14.3% allocation to total small business set-asides under FAR 19.5. This reflects a balanced approach that prioritizes technical capability while actively enabling small business participation across the scientific services ecosystem. Her primary procurement focus lies in NAICS 513210 (software publishers), 334516 (analytical laboratory instrument manufacturing), and 811210 (precision equipment repair), with additional emphasis on testing laboratories (541380) and biological product manufacturing (325414). She routinely acquires next-generation sequencing systems, mass spectrometers, bioinformatics platforms, and validated maintenance services essential to modern biomedical research operations.